Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-40.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-40.7%/yr
vs +15.8%/yr prior
Acceleration
-56.4pp
Decelerating
Percentile
P29
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 6.04% |
| 2024 | -4.62% |
| 2023 | 27.15% |
| 2022 | 28.92% |
| 2021 | 13.53% |
| 2020 | -5.74% |
| 2019 | 9.54% |
| 2018 | 16.11% |
| 2017 | 22.21% |
| 2016 | 12.19% |